← Back to All Filings

Moderna CLO Vests RSUs, Sells Shares for Tax Purposes

Low SignificanceDecember 1, 2025 at 4:34:00 PM EST

Moderna, Inc.

$MRNA4CIK: 0001682852

Subscribe to track MRNA

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Moderna CLO Vests RSUs, Sells Shares for Tax Purposes

Company: Moderna, Inc. (MRNA) Form: 4 | Filed: 2025-12-01 Significance: Low

Insider: Klinger Shannon Thyme Title: Chief Legal Officer | Relationship: Officer

Transaction: • Type: RSU Vesting & Tax Sale • Shares Acquired: 1,102 (Vesting) • Shares Sold: 534 (For Taxes) • Sale Value: ~$13,258 • Owned After: 28,738 shares

Key Insight: This is a routine, non-discretionary transaction related to the insider's compensation plan. The shares were sold automatically to cover tax liabilities from vesting RSUs, not as a discretionary market sale.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Moderna, Inc. (MRNA)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A routine and non-discretionary transaction where the Chief Legal Officer vested Restricted Stock Units (RSUs) and subsequently sold a portion of the shares to cover tax obligations.
  • Market Impact: Negligible, due to the automated nature and small value of the transaction relative to the company's market capitalization.

Company Information

FieldValue
CompanyModerna, Inc.
Ticker SymbolMRNA
CIK0001682852
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameKlinger Shannon Thyme
CIK0001866132
Title/PositionChief Legal Officer
RelationshipOfficer

Transaction Details

This filing reports multiple transactions related to RSU vesting. The primary non-discretionary sale to cover taxes is detailed below.

FieldValue
Form Type4
Transaction Date2025-11-26
Transaction CodeF (Payment of tax liability by withholding securities)
Security TypeCommon Stock
Shares Involved374
Price Per Share$24.75
Total Value$9,256.50
Shares Owned After28,569 (following this specific transaction)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Total Value of Tax Sales$13,258.10
% of Market Cap<0.001%
Total Shares Sold534
% of Shares OutstandingNot Available
Post-Transaction Ownership28,738 shares
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The total transaction value of ~$13k is insignificant against Moderna's market capitalization of $9.68 billion.
  • Transaction Significance: The transactions are coded 'M' (exercise/vesting of derivative) and 'F' (tax withholding). These are automated events tied to executive compensation and do not reflect a discretionary investment decision by the insider. The impact on the market is negligible.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: These are pre-scheduled, non-discretionary transactions common for executive compensation. The small value and automated nature indicate no new information about the company's prospects.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The number of shares is too small to impact trading volume.
  • Sentiment Indicator: Neutral. The market typically ignores routine tax-related sales from insiders.

Additional Context

Transaction Notes

  • Special Circumstances: The filing details the vesting of RSUs and the automatic withholding of shares to satisfy tax obligations, as noted in Footnote F2. This is a standard procedure and not an open-market sale.
Topics:#SECFiling#InsiderTrading#MRNA#Moderna#Form4#StockVesting#ExecutiveComp#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.